MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- GISAID: H5N1 Bird Flu Circulating in Dairy Cows and Poultry in the United States 17 hours ago
- Sub-Antarctic and Antarctic Highly Pathogenic Avian Influenza H5N1 Monitoring Project 17 hours ago
- US: Bovine H5N1 influenza from infected worker transmissible and lethal in animal models 18 hours ago
- GISAID: H5N1 Bird Flu Circulating in Dairy Cows in the United States 3 days ago
- USCDC confirms two human cases of avian influenza in Franklin Co. 4 days ago
[Go Top] [Close Window]